Clinical Trial Update: SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating SBRT in combination with a PD-1 inhibitor and chemotherapy for early-stage triple-negative breast cancer; currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: West China Hospital | Conditions: TNBC - Triple-Negative Breast Cancer | Phase 3 | Status: RECRUITING